Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
July 30, 2024 at 06:59 AM EDT
The results come as Pfizer scrambles to stabilize its business and win back Wall Street’s favor following the rapid decline in demand for its Covid products.
